<DOC>
	<DOCNO>NCT01648660</DOCNO>
	<brief_summary>The primary objective LUTEGA 2 determine long term effect ( 2 year LUTEGA 1 , NCT00763659 ) supplementation fix combination lutein/zeaxanthin omega-3- fatty acid two different dosage optical density ( OD ) macular pigment patient non- exudative age relate maculopathy . The dosage group cross LUTEGA 1 .</brief_summary>
	<brief_title>Long Term Effects Lutein/Zeaxanthin Omega-3- Supplementation Two More Years ( LUTEGA 2 )</brief_title>
	<detailed_description>The LUTEGA 2 cross-over- study continue LUTEGA 1 . After one year supplementation randomize , placebo- control , double blind study ( LUTEGA 1 ) , treatment arm unblind cross different dosage group . The measurement optical density macular pigment ( MPOD ) use 1- wavelength reflection method record reflection image 480 nm fundus camera . The patient follow two year eight visit ( every three month ) In addition MPOD- measurement examination include standardized visual acuity test ( ETDRS ) , amsler- grid , slit lamp biomicroscopy , fundus photography ( color autofluorescence ) blood sample ( every six month ) .</detailed_description>
	<criteria>All non exudative form age relate maculopathy Exudative age relate maculopathy decrease opacity ocular medium</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>